Antiretroviral drug resistance mutations sustain or enhance CTL recognition of common HIV-1 Pol epitopes.
about
Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacyInfluence of HAART on alternative reading frame immune responses over the course of HIV-1 infectionEffects of HIV type-1 immune selection on susceptability to integrase inhibitor resistance.Greater frequency of CD5-negative CD8(+) T cells against human immunodeficiency virus type 1 than other viruses is consistent with adaptation to antigenic variation.Persistence of frequently transmitted drug-resistant HIV-1 variants can be explained by high viral replication capacity.Potential elucidation of a novel CTL epitope in HIV-1 protease by the protease inhibitor resistance mutation L90M.Cytotoxic T cell recognition of an HIV-1 reverse transcriptase variant peptide incorporating the K103N drug resistance mutation.Positioning of APOBEC3G/F mutational hotspots in the human immunodeficiency virus genome favors reduced recognition by CD8+ T cellsThe association between HIV-1 subtype C antiretroviral resistance and HLA prevalence in southern IndiaDifferent Effects of Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations on Cytotoxic T Lymphocyte Recognition between HIV-1 Subtype B and Subtype A/E Infections.Protective genotypes in HIV infection reflect superior function of KIR3DS1+ over KIR3DL1+ CD8+ T cells.Antiretroviral drug therapy alters the profile of human immunodeficiency virus type 1-specific T-cell responses and shifts the immunodominant cytotoxic T-lymphocyte response from Gag to PolStatus and Prospects of Aptamers as Drug Components.CD4+ T cells from HIV-1-infected patients recognize wild-type and mutant human immunodeficiency virus-1 protease epitopes.Identification of a novel resistance (E40F) and compensatory (K43E) substitution in HIV-1 reverse transcriptase.Novel cytotoxic T-lymphocyte escape mutation by a three-amino-acid insertion in the human immunodeficiency virus type 1 p6Pol and p6Gag late domain associated with drug resistanceCross-reactive cytotoxic T lymphocytes against human immunodeficiency virus type 1 protease and gamma interferon-inducible protein 30.Dual selection pressure by drugs and HLA class I-restricted immune responses on human immunodeficiency virus type 1 protease.Tenofovir treatment augments anti-viral immunity against drug-resistant SIV challenge in chronically infected rhesus macaques.The immune response to the RT181-189 epitope in HIV-1-infected patients is associated with viral sequence polymorphism flanking the epitope.Analysis of the diversity of the HIV-1 pol gene and drug resistance associated changes among drug-naïve patients in Burkina Faso.Control of M184V HIV-1 mutants by CD8 T-cell responses.
P2860
Q28473296-D38745C8-A222-472F-A97A-99FF51D77F91Q28480902-57D03EF6-94AE-447A-9DBF-C0FCD126D62AQ34136227-2DB646D2-CB4C-4E5E-B0B8-26DA7CDCCA0CQ34203817-F272D9F3-204F-40A6-B385-ABDAD433A288Q34677368-8C9E2A7A-4732-4D2E-8D9A-84863FED2160Q34981322-0ABC85F1-E3BF-4E87-A531-A79193DD324AQ35090710-19F089C8-0ED4-426F-A150-C066A0A83FA9Q35145382-79249AAC-C343-4B67-B286-6819A570CAB2Q35157869-A2EFD36F-FDE8-4C21-9B79-1DC7203DF8A7Q35758605-11C48186-2D2D-4B8C-B47E-7B844C7C0230Q35846887-069E7237-7633-44CA-A093-8ACB741E2DCAQ36099280-8CCD7CD9-251C-49D8-867C-3672C5EE965BQ38488502-93939CD3-6670-44B4-8794-71F1B28D4C08Q39280285-B4DD5B20-94A4-406D-8D90-BFA75ABC2572Q40013658-BF014CE8-DDC3-4428-818A-B080B19410DDQ41913817-51B0A889-0EA8-4A1D-90C4-E7931287D788Q42723080-FE8BF9A0-DCCA-469B-831F-F526CAE921C1Q42797684-8FE18CE9-B29E-4267-805F-5A4A44D70BEAQ43011767-A1F4ACF9-5ED1-440F-BEC4-3727DE2B9AD9Q43578138-E099A727-4E31-4CCD-9955-6AE8ECF4124EQ43931488-DC077DEB-9755-4E50-B7FA-0681FE7AA36BQ54332318-1C59ACC0-E535-4EA7-A1F8-5F45C6F96DDB
P2860
Antiretroviral drug resistance mutations sustain or enhance CTL recognition of common HIV-1 Pol epitopes.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Antiretroviral drug resistance ...... of common HIV-1 Pol epitopes.
@en
Antiretroviral drug resistance ...... of common HIV-1 Pol epitopes.
@nl
type
label
Antiretroviral drug resistance ...... of common HIV-1 Pol epitopes.
@en
Antiretroviral drug resistance ...... of common HIV-1 Pol epitopes.
@nl
prefLabel
Antiretroviral drug resistance ...... of common HIV-1 Pol epitopes.
@en
Antiretroviral drug resistance ...... of common HIV-1 Pol epitopes.
@nl
P2093
P1476
Antiretroviral drug resistance ...... of common HIV-1 Pol epitopes.
@en
P2093
Constance M Howley
Jennifer C E Myers
M Ian Bowmer
Maureen Gallant
Michael D Grant
Rosemarie D Mason
P304
P356
10.4049/JIMMUNOL.172.11.7212
P407
P577
2004-06-01T00:00:00Z